L. Roy Papp & Associates LLP Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

L. Roy Papp & Associates LLP lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 154,614 shares of the exchange traded fund’s stock after selling 1,158 shares during the quarter. SPDR S&P Biotech ETF comprises about 1.8% of L. Roy Papp & Associates LLP’s investment portfolio, making the stock its 18th biggest holding. L. Roy Papp & Associates LLP owned 0.20% of SPDR S&P Biotech ETF worth $15,276,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in XBI. ORG Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $40,000. ORG Wealth Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $44,000. Waldron Private Wealth LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $54,000. Resources Management Corp CT ADV boosted its holdings in shares of SPDR S&P Biotech ETF by 30.3% in the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares during the last quarter. Finally, Lynx Investment Advisory purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $58,000.

SPDR S&P Biotech ETF Trading Down 0.1 %

NYSEARCA XBI traded down $0.10 on Friday, reaching $97.15. 6,256,079 shares of the stock were exchanged, compared to its average volume of 9,406,488. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The firm has a market capitalization of $7.40 billion, a PE ratio of 11.47 and a beta of 1.11. The company’s 50-day simple moving average is $99.14 and its two-hundred day simple moving average is $94.62.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.